Overview

Compare the Effect of DPP-IV Inhibitor or TZD on Glycemic Variability and Oxidative Stress in Patient With 2 Diabetes

Status:
Unknown status

Trial end date:
2013-05-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to compare the effect of vildagliptin vs. pioglitazone to oxidative stress on daily blood glucose fluctuations, in patients with type 2 diabetes that was inadequately controlled by metformin.

Phase:

Phase 4

Details

Lead Sponsor:

Korea University Anam Hospital

Treatments:

Pioglitazone
Vildagliptin